# Nuclide record paper-eanm-lu177-dosimetry-recommendations-ejnmmi-2022 (paper). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/key-papers/paper-eanm-lu177-dosimetry-recommendations-ejnmmi-2022/>
  a schema:ScholarlyArticle ;
  nuclide:kind "paper" ;
  schema:identifier "paper-eanm-lu177-dosimetry-recommendations-ejnmmi-2022" ;
  schema:name "EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands"@en ;
  schema:description "European nuclear medicine physicists set out a detailed, agreed method for measuring exactly how much radiation dose a patient's kidneys and tumours actually receive during lutetium-177 treatments, so that dosing can eventually be tailored to the individual rather than fixed for everyone."@en ;
  schema:url <https://nuclide.cc/key-papers/paper-eanm-lu177-dosimetry-recommendations-ejnmmi-2022/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://eanm.org/publications/guidelines/overview/dosimetry/>, <https://pmc.ncbi.nlm.nih.gov/articles/PMC9015994/> ;
  nuclide:tag "guideline", "dosimetry", "lutetium-177" ;
  schema:sameAs <https://doi.org/10.1007/s00259-022-05727-7> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Sjögreen Gleisner K, Chouin N, Gabina PM, Cicone F, Gnesin S, et al." ;
  nuclide:related <https://nuclide.cc/technologies/radioligand-dosimetry/>, <https://nuclide.cc/terms/dosimetry/>, <https://nuclide.cc/technologies/prrt/>, <https://nuclide.cc/technologies/lu177-radioligand-therapy/>, <https://nuclide.cc/drugs/pluvicto/>, <https://nuclide.cc/institutions/eanm/>, <https://nuclide.cc/terms/gray-unit/>, <https://nuclide.cc/isotopes/lu-177/> .
